Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

The Immunological Profile of Adipose Mesenchymal Stromal/Stem Cells after Cell Expansion and Inflammatory Priming.

Buyl K., Merimi M., Rodrigues RM., Rahmani S., Fayyad-Kazan M., Bouhtit F.

Laboratory Study on Face & Skin, published in Biomolecules (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Biomolecules (2024)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
39062566
PMCID
PMC11275169
DOI
10.3390/biom14070852
Citations
2

Abstract (original English)

Background AT-MSCs display great immunoregulatory features, making them potential candidates for cell-based therapy. This study aimed to evaluate the "RBC lysis buffer" isolation protocol and immunological profiling of the so-obtained AT-MSCs. Methods We established an immune-comparative screening of AT-MSCs throughout in vitro cell expansion (PM, P1, P2, P3, P4) and inflammatory priming regarding the expression of 28 cell-surface markers, 6 cytokines/chemokines, and 10 TLR patterns. Findings AT-MSCs were highly expandable and sensitive to microenvironment challenges, hereby showing plasticity in distinct expression profiles. Both cell expansion and inflammation differentially modulated the expression profile of CD34, HLA-DR, CD40, CD62L, CD200 and CD155, CD252, CD54, CD58, CD106, CD274 and CD112. Inflammation resulted in a significant increase in the expression of the cytokines IL-6 , IL-8 , IL-1β , IL-1Ra , CCL5 , and TNFα . Depending on the culture conditions, the expression of the TLR pattern was distinctively altered with TLR1-4 , TLR7 , and TLR10 being increased, whereas TLR6 was downregulated. Protein network and functional enrichment analysis showed that several trophic and immune responses are likely linked to these immunological changes. Conclusions AT-MSCs may sense and actively respond to tissue challenges by modulating distinct and specific pathways to create an ap

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansMesenchymal Stem CellsInflammationCytokinesAdipose TissueCell ProliferationCells, CulturedAdultToll-Like ReceptorsFemale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research